From the aDivision of Plastic and Reconstructive Surgery

bDepartment of Surgery, University of California, Los Angeles David Geffen School of Medicine

cLouise M. Darling Biomedical Library, University of California, Los Angeles, Los Angeles, CA.

Received February 8, 2023, and accepted for publication, after revision April 30, 2023.

This trial is registered under the name “The Role of Postoperative Antibiotics following Primary and Secondary Breast Augmentation: A Systematic Review of Literature.” PROSPERO identification no. CRD42021287059.

Conflicts of interest and sources of funding: All authors have no financial interests including products, devices, or drugs associated with this manuscript. There are no commercial associations that might pose or create a conflict of interest with information presented in this submitted manuscript such as consultancies, stock ownership, or patent licensing arrangements. All sources of funds supporting the completion of this manuscript are under the auspices of the University of California Los Angeles.

Data access: All data collected for this research are reported in the manuscript and accompanying supplement.

Ethical consideration: This is a systematic review and did not involve patient-level data; therefore, this work did not require institutional review board approval.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s Web site (www.annalsplasticsurgery.com).

Reprints: Karie Villanueva, MD, Division of Plastic and Reconstructive Surgery, Department of Surgery, University of California, Los Angeles, 200 Medical Plaza, Suite 460, Los Angeles, CA 90095. E-mail: [email protected].